pediatric patient / parent

I am a pediatric hematologic oncologist and Chief of the Pediatric Stem Cell Transplantation and Cellular Therapies Service. I specialize in bone marrow and cord blood transplantation to treat blood diseases in children and young adults. I have particular expertise caring for people with rare diseases, such as lysosomal storage disorders like Hurler’s disease and leukodystrophies like metachromatic leukodystrophy, adrenoleukodystrophy, and Krabbe disease. I am also part of a dedicated team of experts working to develop new treatments for our young patients. At MSK Kids, our goal is to better

Kendall Downer, MD is a Clinical Assistant Professor of Medicine in the Department of Medicine, Division of General Internal Medicine, Section of Palliative Care and Medical Ethics at the University of Pittsburgh. She completed medical school training at the Icahn School of Medicine at Mount Sinai, internal medicine residency at the University of Pittsburgh Medical Center and hospice and palliative medicine fellowship at the University of Alabama at Birmingham. Her clinical responsibilities include providing inpatient Supportive and Palliative Care consultation at UPMC Presbyterian and

I am a hematologist specializing in the treatment of myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN) and clonal cytopenias of unknown significance. I received my Master of Science in pathobiology and molecular medicine from the University of Cincinnati, and completed a fellowship in hematology/oncology at the University of Alabama. As a member of the Leukemia Research Program at the OSUCCC – James, my clinical and translational research focus is on novel therapeutics in myeloid diseases, with a special focus in disease progression from

My research focuses on identifying the genetic causes of human diseases as a means to both better diagnosis and treat patients and understand basic biologic principles. We are interested in studying autoimmune and auto-inflammatory diseases to elucidate the mechanism underlying these diseases and improve patient care. We use a combination of genetic, and biochemical approaches in patient derived and animal models to better understand these diseases. Our aim is to directly connect human diseases with basic innate immune biology using genetics.